Publication | Closed Access

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

HypertensionCardiovascular DiseaseEndpoint ReductionRandomised TrialAntihypertensive TherapyCardiovascular PharmacologyLosartan InterventionMedicineEmergency MedicineAnesthesiology